Green Thumb Industries’ Annual General Meeting, Elects Directors And Approves Executive Compensation
Read about the key outcomes of Green Thumb Industries' 2024 AGM, including director elections and approval of executive compensation.
Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks
New Jersey Cannabis Most Expensive In The Nation: State Senator Has A Solution For Medicinal Users
Medicinal users face significant financial burdens, while lawmakers propose two potential solutions: home cultivation and price caps.
New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia
Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia
Cannabis-Focused Software Co. Springbig Sees Slight Q1 Revenue Decline But Improves Net Loss, Keeps Full Year Financial Guidance
Paul Sykes, CFO, remarked on achieving a positive adjusted EBITDA for the first time at $0.2 million, compared to a loss of $1.3M last year
Planet 13 Wraps Up VidaCann Acquisition To Enter Florida Market With $63.4M Deal And 26 Cannabis Dispensaries
Las Vegas-based cannabis giant, Planet 13 Holdings Inc. has successfully concluded its acquisition of Florida's VidaCann
New Chapter In Merger Court Battle Among These Two Cannabis Companies
Goodness Growth and Verano's court battle continues as Verano seeks damages over a terminated acquisition agreement.
Colombian Company Ships First Ever Batch Of Cannabis Essential Oil To Boston
Colombian cannabis company Sannabis makes U.S. debut with essential oil shipment, navigating regulatory hurdles while exploring industry potential and partnerships
New Tax Rules In Cannabis: What Are The Consequences DEA Rescheduling?
Discover the transformative effects of marijuana rescheduling on the cannabis industry, focusing on tax relief, financial improvements...
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion
"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.